Advanced Instruments to acquire and merge with Nova Biomedical in USD 2.2 billion deal

Recent work|March 26, 2025

Advanced Instruments, a subsidiary of Patricia Industries (part of Investor AB), has entered into a definitive agreement to acquire Nova Biomedical from its founding shareholders for an enterprise value of USD 2.2 billion.

Advanced Instruments is a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The combination of Advanced Instruments and Nova Biomedical will create a diversified, global life science tools platform, which will operate under the Nova Biomedical name. Closing is subject to approval by relevant regulatory authorities and is expected during the third quarter of 2025.

Roschier advised Investor AB on the transaction.

Roschier’s advisory team comprised Jeppa Persson, Sam Naderi, Malin Leffler, and Pontus Enquist.